Literature DB >> 11451704

Influence of liposomal amphotericin B on CD8 T-cell function.

M Kretschmar1, G Geginat, T Bertsch, S Walter, H Hof, T Nichterlein.   

Abstract

Liposomal amphotericin B was immunosuppressive on target cell lysis in vitro and on protection mediated by cytotoxic CD8 T cells in murine listeriosis. When dosages usually used for therapy in humans were compared, the immunosuppressive effect of 5 mg of liposomal amphotericin B/kg of body weight/day was similar to that of standard amphotericin B at 1 mg/kg/day, but a dosage of liposomal amphotericin B of 1 mg/kg/day was not suppressive in vivo.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11451704      PMCID： PMC90661          DOI： 10.1128/AAC.45.8.2383-2385.2001

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  15 in total

Review 1.  Murine listeriosis as a model of antimicrobial defense.

Authors:  R J North; P L Dunn; J W Conlan
Journal:  Immunol Rev       Date:  1997-08       Impact factor: 12.988

2.  Effect of liposomal amphotericin B on murine macrophages and lymphocytes.

Authors:  R T Mehta; K Mehta; G Lopez-Berestein; R L Juliano
Journal:  Infect Immun       Date:  1985-02       Impact factor: 3.441

Review 3.  Liposomal amphotericin B. Therapeutic use in the management of fungal infections and visceral leishmaniasis.

Authors:  A J Coukell; R N Brogden
Journal:  Drugs       Date:  1998-04       Impact factor: 9.546

4.  Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America.

Authors:  D A Stevens; V L Kan; M A Judson; V A Morrison; S Dummer; D W Denning; J E Bennett; T J Walsh; T F Patterson; G A Pankey
Journal:  Clin Infect Dis       Date:  2000-04-20       Impact factor: 9.079

5.  Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America.

Authors:  J H Rex; T J Walsh; J D Sobel; S G Filler; P G Pappas; W E Dismukes; J E Edwards
Journal:  Clin Infect Dis       Date:  2000-04-20       Impact factor: 9.079

6.  Enhancement of the Listeria monocytogenes p60-specific CD4 and CD8 T cell memory by nonpathogenic Listeria innocua.

Authors:  G Geginat; T Nichterlein; M Kretschmar; S Schenk; H Hof; M Lalic-Mülthaler; W Goebel; A Bubert
Journal:  J Immunol       Date:  1999-04-15       Impact factor: 5.422

7.  Effect of amphotericin B on natural killer cell activity in vitro.

Authors:  W E Hauser; J S Remington
Journal:  J Antimicrob Chemother       Date:  1983-03       Impact factor: 5.790

8.  Suppression of acquired immunity against Listeria monocytogenes by amphotericin B-mediated inhibition of CD8 T cell function.

Authors:  G Geginat; M Kretschmar; S Walter; D Junker; H Hof; T Nichterlein
Journal:  J Infect Dis       Date:  1999-10       Impact factor: 5.226

9.  Immunological effects of amphotericin B and liposomal amphotericin B on splenocytes from immune-normal and immune-compromised mice.

Authors:  J J Schindler; R P Warren; S D Allen; M K Jackson
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

10.  Liposomal amphotericin B inhibits in vitro T-lymphocyte response to antigen.

Authors:  J M Boggs; N H Chang; A Goundalkar
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191
View more
  6 in total

1.  Antifungal Drugs Influence Neutrophil Effector Functions.

Authors:  Frederic Ries; Astrid Alflen; Pamela Aranda Lopez; Hendrik Beckert; Matthias Theobald; Hansjörg Schild; Daniel Teschner; Markus Philipp Radsak
Journal:  Antimicrob Agents Chemother       Date:  2019-05-24       Impact factor: 5.191

2.  Hemophagocytic lymphohistiocytosis associated with visceral leishmaniasis in late adulthood.

Authors:  Guilherme Grossi Lopes Cançado; Guilherme Gomes Freitas; Flavia Helena Fidelis Faria; Antonio Vaz de Macedo; Vandack Nobre
Journal:  Am J Trop Med Hyg       Date:  2013-01-16       Impact factor: 2.345

3.  Impact of Antifungal Compounds on Viability and Anti-Aspergillus Activity of Human Natural Killer Cells.

Authors:  Stanislaw Schmidt; Ralf Schubert; Lars Tramsen; Thomas Lehrnbecher
Journal:  Antimicrob Agents Chemother       Date:  2019-01-29       Impact factor: 5.191

4.  Voriconazole inhibits fungal growth without impairing antigen presentation or T-cell activation.

Authors:  Heather L Van Epps; Marta Feldmesser; Eric G Pamer
Journal:  Antimicrob Agents Chemother       Date:  2003-06       Impact factor: 5.191

5.  Tissue-specific transcriptomic changes associated with AmBisome® treatment of BALB/c mice with experimental visceral leishmaniasis.

Authors:  Sarah Forrester; Karin Siefert; Helen Ashwin; Najmeeyah Brown; Andrea Zelmar; Sally James; Dimitris Lagos; Jon Timmis; Mitali Chatterjee; Jeremy C Mottram; Simon L Croft; Paul M Kaye
Journal:  Wellcome Open Res       Date:  2019-12-10

6.  Immunotherapy of invasive fungal infection in hematopoietic stem cell transplant recipients.

Authors:  Thomas Lehrnbecher; Stanislaw Schmidt; Lars Tramsen; Thomas Klingebiel
Journal:  Front Oncol       Date:  2013-02-07       Impact factor: 6.244
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.